The Big Ones That Got Away: Omega-3 Meta-analysis Flawed by Excluding the Biggest Fish Oil Trials—Reply

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · see citing works

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · see citing works

n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction

Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936 · see citing works

Untitled work

Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368 · see citing works

Efficacy of n‐3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI‐prevenzione trial

Marchioli, R., Schweiger, C., Tavazzi, L., & Valagussa, F. (2001) · Lipids · doi:10.1007/s11745-001-0694-8 · Cited by 131 · see citing works

The 2015 Dutch food-based dietary guidelines

Kromhout, D., Spaaij, C. J. K., de Goede, J., & Weggemans, R. M. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.52 · Cited by 400 · see citing works

Marine Omega‐3 Supplementation and Cardiovascular Disease: An Updated Meta‐Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants

Hu, Y., Hu, F. B., & Manson, J. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013543 · Cited by 388 · see citing works

Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations

Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138 · see citing works

Inflammation and cardiovascular disease: are marine phospholipids the answer?

Lordan, R., Redfern, S., Τσούπρας, Α., & Zabetakis, I. (2020) · Food & Function · doi:10.1039/c9fo01742a · Cited by 103 · see citing works

Update on cardiometabolic health effects of ω-3 fatty acids

Kromhout, D., & de Goede, J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000041 · Cited by 101 · see citing works

Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors

Mori, T. A. (2014) · Food & Function · doi:10.1039/c4fo00393d · Cited by 77 · see citing works

Are n-3 fatty acids still cardioprotective?

Harris, W. S. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835bf380 · Cited by 57 · see citing works

Hypertriglyceridemia and Cardiovascular Diseases: Revisited

Han, S. H., Nicholls, S. J., Sakuma, I., Zhao, D. H., & Koh, K. K. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.2.135 · Cited by 57 · see citing works

Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementation

Messamore, E., & McNamara, R. K. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0196-5 · Cited by 57 · see citing works

The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review

Talebi, S., Bagherniya, M., Atkin, S. L., Askari, G., Orafai, H. M., & Sahebkar, A. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01250-6 · Cited by 54 · see citing works

Nutrient reference value: non-communicable disease endpoints—a conference report

Lupton, J. R., Blumberg, J. B., L’Abbé, M. R., LeDoux, M., Rice, H. B., von Schacky, C., Yaktine, A. L., & Griffiths, J. C. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1195-z · Cited by 51 · see citing works

Effects of Eicosapentaenoic Acid on the Levels of Inflammatory Markers, Cardiac Function and Long-Term Prognosis in Chronic Heart Failure Patients with Dyslipidemia

Kohashi, K., Nakagomi, A., Saiki, Y., Morisawa, T., Kosugi, M., Kusama, Y., Atarashi, H., & Shimizu, W. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.21022 · Cited by 46 · see citing works

Long‐Term Administration of Eicosapentaenoic Acid Improves Post–Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization

Takamura, M., Kurokawa, K., Ootsuji, H., Inoue, O., Okada, H., Nomura, A., Kaneko, S., & Usui, S. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004560 · Cited by 45 · see citing works

Comparison of fatty acid intakes assessed by a cardiovascular-specific food frequency questionnaire with red blood cell membrane fatty acids in hyperlipidaemic Australian adults: a validation study

Schumacher, T. L., Burrows, T. L., Rollo, M. E., Wood, L. G., Callister, R., & Collins, C. E. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.144 · Cited by 39 · see citing works

Omega-3 fatty acids and coronary heart disease. The final verdict?

Kromhout, D. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328359515f · Cited by 35 · see citing works

Immobilized phospholipase A1-catalyzed acidolysis of phosphatidylcholine from Antarctic krill (Euphausia superba) for docosahexaenoic acid enrichment under supercritical conditions

Xi, X., Feng, X., Shi, N., Ma, X., Lin, H., & Han, Y. (2016) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/j.molcatb.2016.01.011 · Cited by 33 · see citing works

Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

Rizos, E. C., & Elisaf, M. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0856-8 · Cited by 31 · see citing works

Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins

Minihane, A. M. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.19 · Cited by 30 · see citing works

Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes

Matikainen, N., & Taskinen, M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0309-3 · Cited by 24 · see citing works

Macronutrient replacement options for saturated fat: effects on cardiovascular health

Flock, M., Fleming, J., & Kris-Etherton, P. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000039 · Cited by 21 · see citing works

Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients

Eide, I. A., Dahle, D. O., Svensson, M. H. S., Hartmann, A., Åsberg, A., Bjerve, K. S., Christensen, J., Schmidt, E. B., Lauritsen, M. E., Lund, K., et al. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.14 · Cited by 17 · see citing works

Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN® REVEAL Trial

Shaikh, N. A., Yantha, J., Shaikh, S., Rowe, W., Laidlaw, M., Cockerline, C., Ali, A., Holub, B., & Jackowski, G. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2132-1 · Cited by 16 · see citing works

Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation—A Meta-Regression of Randomized Trials

Sethi, A., Bajaj, A., Khosla, S., & Arora, R. R. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000048 · Cited by 16 · see citing works

Epanova ® and Hypertriglyceridemia: Pharmacological Mechanisms and Clinical Efficacy

Kataoka, Y., Uno, K., Puri, R., & Nicholls, S. J. (2013) · Future Cardiology · doi:10.2217/fca.13.4 · Cited by 13 · see citing works

Dietary fatty acids in health and disease

Calder, P. C., & Deckelbaum, R. J. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000038 · Cited by 12 · see citing works

A comprehensive review of lipase-catalyzed acidolysis as a method for producing structured glycerides

Tacias-Pascacio, V. G., Abellanas-Pérez, P., de Andrades, D., Tavano, O. L., MENDES, A. A., Berenguer‐Murcia, Á., & Fernández‐Lafuente, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142878 · Cited by 12 · see citing works

Polyunsaturated fatty acids in serum and homocysteine concentrations in Japanese men and women: a cross-sectional study

Kume, A., Kurotani, K., Sato, M., Ejima, Y., Pham, N. M., Nanri, A., Kuwahara, K., & Mizoue, T. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-41 · Cited by 10 · see citing works

Why are there inconsistencies in the outcomes of some omega-3 fatty acid trials for the management of cardiovascular disease?

Shaikh, N., & Tappia, P. S. (2015) · Clinical Lipidology · doi:10.2217/clp.15.1 · Cited by 10 · see citing works

n-3 Fatty acids and cardiovascular disease: the story is not over yet

Bilato, C. (2013) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0077-y · Cited by 7 · see citing works

What Can Comparative Effectiveness Research Contribute to Integrative Health in International Perspective?

Witt, C. M., Withers, S. R., Grant, S. J., Lauer, M. S., Tunis, S., & Berman, B. (2014) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0073 · Cited by 6 · see citing works

Experimental and computational studies of fatty acid distribution networks

Liu, Y., Buendía-Rodríguez, G., Peñuelas-Rívas, C. G., Tan, Z., Rívas-Guevara, M., Tenorio-Borroto, E., Munteanu, C. R., Pazos, A., & González‐Díaz, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00325c · Cited by 6 · see citing works

Mass Spectrometric Analysis of Oxidized Eicosapentaenoic Acid Sodium Salt

Jordan, K. D., & Upmacis, R. K. (2013) · Lipid Insights · doi:10.4137/lpi.s10862 · Cited by 6 · see citing works

Use of Omega‐3 Fatty Acid Supplements Has Insufficient Clinical Evidence for Treatment of Hypertriglyceridemia: A Meta‐Analysis of Randomized, Double‐Blind, Placebo‐Controlled Trials

Nam, G. E., Myung, S., & Choi, Y. (2017) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201700111 · Cited by 5 · see citing works

Protection against Incidences of Serious Cardiovascular Events Study with daily fish oil supplementation in dialysis patients (PISCES): protocol for a randomised controlled trial

Lok, C. E., Hemmelgarn, B. R., MOIST, L. M., Polkinghorne, K. R., TOMLINSON, G. A., & Tonelli, M. A. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-072239 · Cited by 3 · see citing works

Systematic Reviews in the Field of Nutrition

Lichtenstein, A. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_2 · Cited by 2 · see citing works

n-3 and n-6 Fatty Acids Reduce Risk for Cardiovascular Disease

Harris, W. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-22431-2_14 · Cited by 1 · see citing works

The Law for Health Functional Foods, It is Time to Repeal

Myung, S. (2017) · Journal of Korean Diabetes · doi:10.4093/jkd.2017.18.4.205 · Cited by 1 · see citing works

Visolievetzuren en cardiovasculaire incidenten

Kerst, A., & Bijl, D. (2014) · TvPO · doi:10.1007/s12503-014-0069-1

Supplement Doubts Spread to Omega-3 Fatty Acids for Cardiovascular Disease Prevention

Lomangino, K. (2012) · Clinical Nutrition INSIGHT · doi:10.1097/01.nmd.0000418664.35830.9c

Vitamins and Dietary Supplements for the Older Adult: What Works and Why?

Saad, M., Fausto, N., & Maisch, N. M. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000669

Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines

Djordjevic, D. B., Đorđević, A. D., & Lović, D. B. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00173-w

Bipolar Disorder

Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_22-1

Bipolar Disorder

Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_22

The Big Ones That Got Away: Omega-3 Meta-analysis Flawed by Excluding the Biggest Fish Oil Trials

DiNicolantonio, J. J., O’Keefe, J. H., & Lavie, C. J. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3755 · Cited by 9 · see citing works

The Flaws of Recent Omega-3 Clinical Trials Should Not Prevent Their Use.

DiNicolantonio, J. J., & O’Keefe, J. H. (2021) · PubMed Central

Omega-3 Fatty Acid Therapy: A Review of Study Design Flaws, Quality, and Composition

Hands, J. M., & Frame, L. A. (2024) · Medical Research Archives · doi:10.18103/mra.v12i4.5273

Something fishy: The issue of omega-3 blinding in psychiatric clinical trials

Liu, J. C., Ang, R. P.-H., & Fung, D. S. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412451343 · Cited by 5 · see citing works

Explaining the Recent Fish Oil Trial “Failures”

Niazi, J. J. D. A. K. (2013) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000e112 · Cited by 5 · see citing works